Evolving Knowledge of the Teratogenicity of Medications in Human Pregnancy

被引:247
作者
Adam, Margaret P. [1 ]
Polifka, Janine E. [2 ,3 ]
Friedman, J. M. [4 ,5 ,6 ]
机构
[1] Univ Washington, Div Med Genet, Seattle, WA 98195 USA
[2] Univ Washington, Dept Pediat, Seattle, WA 98195 USA
[3] Univ Washington, Ctr Human Dev & Disabil, Seattle, WA 98195 USA
[4] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[5] UBC Fac Med, Vancouver, BC, Canada
[6] Canadian Coll Med Geneticists, Vancouver, BC, Canada
关键词
TERATOGEN; DRUG SAFETY; BIRTH DEFECTS; PREGNANCY; SURVEILLANCE; TRENDS; PRESCRIPTION DRUG-USE; DEVELOPMENTAL TOXICITY; DEFECTS; TERATOLOGY; LACTATION; EXPOSURE; RISKS;
D O I
10.1002/ajmg.c.30313
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
A majority of pregnant women take at least one medication during pregnancy, although the safety of such drugs during pregnancy is not always known. We reviewed the safety during pregnancy of 172 drugs approved by the US Food and Drug Administration (FDA) from 2000 to 2010 using the TERIS risk rating system. We also reviewed safety information for 468 drugs approved by the FDA from 1980 to 2000 to determine if revisions in risk categories had been made in the last 10 years. The teratogenic risk in human pregnancy was "undetermined'' for 168 (97.7%) of drug treatments approved between 2000 and 2010. Furthermore, the amount of data available regarding safety in pregnancy was rated as "none'' for 126 (73.3%) of these drugs. For those drugs approved between 1980 and 2000, only 23 (5%) changed a full risk category or more in the past 10 years. Sources of data that led to a revised risk were derived from exposure cohort studies performed through record linkage studies, teratogen information services, large population-based case-control studies, and pregnancy registries. The mean time for a treatment initially classified as having an "undetermined'' risk to be assigned a more precise risk was 27 years (95% confidence interval 26-28 years). The lack of information needed to assess the safety of drug treatments during human pregnancy remains a serious public health problem. A more active approach to post-marketing surveillance for teratogenic effects is necessary. (C) 2011 Wiley-Liss, Inc.
引用
收藏
页码:175 / 182
页数:8
相关论文
共 39 条
[1]   Addendum: Sartan treatment during pregnancy [J].
Alwan, S ;
Polifka, JE ;
Friedman, JM .
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2005, 73 (11) :904-905
[2]   Angiotensin II receptor antagonist treatment during pregnancy [J].
Alwan, S ;
Polifka, JE ;
Friedman, JM .
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2005, 73 (02) :123-130
[3]   Prescription drug use in pregnancy [J].
Andrade, Susan E. ;
Gurwitz, Jerry H. ;
Davis, Robert L. ;
Chan, K. Arnold ;
Finkelstein, Jonathan A. ;
Fortman, Kris ;
McPhillips, Heather ;
Raebel, Marsha A. ;
Roblin, Douglas ;
Smith, David H. ;
Yood, Marianne Ulcickas ;
Morse, Abraham N. ;
Platt, Richard .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (02) :398-407
[4]  
BENGT K, 1988, EPIDEMIOLOGY HUMAN R
[5]   Paper 1: The EUROCAT Network-Organization and Processes [J].
Boyd, Patricia A. ;
Haeusler, Martin ;
Barisic, Ingeborg ;
Loane, Maria ;
Garne, Ester ;
Dolk, Helen .
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2011, 91 :S2-S15
[6]  
Briggs G.G., 2011, Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk
[7]   Medications in Pregnancy and Lactation Part 2. Drugs With Minimal or Unknown Human Teratogenic Effect [J].
Buhimschi, Catalin S. ;
Weiner, Carl P. .
OBSTETRICS AND GYNECOLOGY, 2009, 113 (02) :417-432
[8]   Value of the small cohort study including a physical examination for minor structural defects in identifying new human teratogens [J].
Chambers, Christina D. .
CONGENITAL ANOMALIES, 2011, 51 (01) :16-20
[9]   Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data [J].
Chambers, Christina D. ;
Tutuncu, Zuhre N. ;
Johnson, Diana ;
Jones, Kenneth L. .
ARTHRITIS RESEARCH & THERAPY, 2006, 8 (04)
[10]   Diagnostic Radiation in Pregnancy: Perception Versus True Risks [J].
Cohen-Kerem, Raanan ;
Nulman, Irena ;
Abramow-Newerly, Maria ;
Medina, Damien ;
Mazel, Ronnen ;
Brent, Robert L. ;
Koren, Gideon .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2006, 28 (01) :43-48